- Active ingredient:
- Gliclazide 60.00 mg
- Pharmaceutical form:
- Modified-release, divisible tablet; white in color, with notches on both sides; oblong tablet; the tablet can be divided into 2 equal parts.
- Route of administration:
- For oral use. For adults only. The tablet(s) should be swallowed whole without chewing. If a dose is missed, do not take a double dose the next day. As with all hypoglycemic agents, the dose should be adjusted based on the patient’s metabolic response (blood glucose, HbA1c).